[Regulation of telomerase and its clinical application in blood cells].
Yamada
Osamu
O
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001773:Blood Cells / Q000166:cytology / Q000201:enzymology; D002454:Cell Differentiation; D019008:Drug Resistance, Neoplasm; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D015316:Genetic Therapy / Q000379:methods; D019337:Hematologic Neoplasms / Q000097:blood / Q000201:enzymology / Q000473:pathology / Q000628:therapy*; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000201:enzymology; D006801:Humans; D008214:Lymphocytes / Q000201:enzymology / Q000276:immunology; D033581:Stem Cell Transplantation; D019098:Telomerase / Q000037:antagonists & inhibitors* / Q000097:blood* / Q000737:chemistry / Q000502:physiology; D016615:Telomere / Q000737:chemistry / Q000235:genetics / Q000502:physiology
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D019098:Telomerase